Dr. Erika Maestas
Claim this profileUniversity of New Mexico Cancer Center
Studies Adenocarcinoma
Studies Cancer
3 reported clinical trials
6 drugs studied
Area of expertise
1Adenocarcinoma
Stage IV
BRCA1 positive
BRCA2 positive
2Cancer
p16 positive
p16 negative
BRCA1 positive
Affiliated Hospitals
Clinical Trials Erika Maestas is currently running
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting2 awards Phase 32 criteria
More about Erika Maestas
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Erika Maestas has experience with
- Olaparib
- Cisplatin
- Radiation Therapy
- MFOLFIRINOX
- MFOLFOX
- Nivolumab
Breakdown of trials Erika Maestas has run
Adenocarcinoma
Cancer
Pancreatic Cancer
Adenosquamous Carcinoma
Acinar Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erika Maestas specialize in?
Erika Maestas focuses on Adenocarcinoma and Cancer. In particular, much of their work with Adenocarcinoma has involved Stage IV patients, or patients who are BRCA1 positive.
Is Erika Maestas currently recruiting for clinical trials?
Yes, Erika Maestas is currently recruiting for 3 clinical trials in Albuquerque New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Erika Maestas has studied deeply?
Yes, Erika Maestas has studied treatments such as Olaparib, Cisplatin, Radiation Therapy.
What is the best way to schedule an appointment with Erika Maestas?
Apply for one of the trials that Erika Maestas is conducting.
What is the office address of Erika Maestas?
The office of Erika Maestas is located at: University of New Mexico Cancer Center, Albuquerque, New Mexico 87106 United States. This is the address for their practice at the University of New Mexico Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.